Characteristic Patterns of Relapse After Allogeneic Hematopoietic SCT for Adult T-cell Leukemia-lymphoma: a Comparative Study of Recurrent Lesions After Transplantation and Chemotherapy by the Nagasaki Transplant Group

Overview

Journal Bone Marrow Transplant

Specialty General Surgery

Date 2015 Jan 27

PMID 25621801

Authors

H Itonaga

Y Sawayama

J Taguchi

S Honda

H Taniguchi

J Makiyama

E Matsuo

S Sato

K Ando

D Imanishi

Y Imaizumi

S Yoshida

T Hata

Y Moriuchi

T Fukushima

Y Miyazaki

Affiliations

Soon will be listed here.

Abstract

Allogeneic hematopoietic SCT (allo-SCT) is a promising therapy that may provide long-term durable remission for adult T-cell leukemia-lymphoma (ATL) patients; however, the incidence of relapse associated with ATL remains high. To determine the clinical features of these patients at relapse, we retrospectively analyzed tumor lesions in 30 or 49 patients who relapsed following allo-SCT or chemotherapy (CHT), respectively, at three institutions in Nagasaki prefecture between 1997 and 2011. A multivariate analysis revealed that the development of abnormal lymphocytes in the peripheral blood of patients at relapse was less frequent after allo-SCT than after CHT (P<0.001). Furthermore, relapse with a new lesion only in the absence of the primary lesion was more frequent in allo-SCT (P=0.014). Lesions were more frequently observed in the central nervous systems of patients who relapsed with new lesions only (P=0.005). Thus, the clinical manifestation of relapsed ATL was slightly complex, especially in post-transplant patients. Our results emphasized the need to develop adoptive modalities for early and accurate diagnoses of relapsed ATL.

References

Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M . A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol. 2001; 113(2):375-82. DOI: 10.1046/j.1365-2141.2001.02737.x. View

Fukushima T, Itonaga H, Moriuchi Y, Yoshida S, Taguchi J, Imaizumi Y . Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation Network. Int J Hematol. 2013; 97(4):485-90. DOI: 10.1007/s12185-013-1307-y. View

Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M . Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009; 15(3):367-9. PMC: 3110087. DOI: 10.1016/j.bbmt.2008.12.497. View

Tanosaki R, Uike N, Utsunomiya A, Saburi Y, Masuda M, Tomonaga M . Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant. 2008; 14(6):702-8. DOI: 10.1016/j.bbmt.2008.03.010. View

Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S . Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. Biol Blood Marrow Transplant. 2007; 13(1):90-9. DOI: 10.1016/j.bbmt.2006.09.002. View

Yoshihara S, Ando T, Ogawa H . Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse. Biol Blood Marrow Transplant. 2012; 18(12):1800-7. DOI: 10.1016/j.bbmt.2012.05.010. View

Simone 2nd C, Morris J, Stewart D, Urquhart N, Janik J, Kreitman R . Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphoma. Blood. 2012; 120(9):1816-9. PMC: 3433088. DOI: 10.1182/blood-2012-01-401349. View

Cook L, Melamed A, Niederer H, Valganon M, Laydon D, Foroni L . The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. Blood. 2014; 123(25):3925-31. PMC: 4064332. DOI: 10.1182/blood-2014-02-553602. View

Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H, Hanada S . Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma. J Clin Oncol. 2012; 30(14):1635-40. DOI: 10.1200/JCO.2011.38.2101. View

10.

Shiratori S, Yasumoto A, Tanaka J, Shigematsu A, Yamamoto S, Nishio M . A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Biol Blood Marrow Transplant. 2008; 14(7):817-23. DOI: 10.1016/j.bbmt.2008.04.014. View

11.

Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M . Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood. 2005; 105(10):4143-5. DOI: 10.1182/blood-2004-11-4193. View

12.

Potenza L, Luppi M, Riva G, Morselli M, Ferrari A, Imovilli A . Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: case report and review of the literature. Am J Hematol. 2005; 81(1):45-50. DOI: 10.1002/ajh.20421. View

13.

. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987). Leuk Res. 1991; 15(2-3):81-90. DOI: 10.1016/0145-2126(91)90087-a. View

14.

Takasaki Y, Iwanaga M, Imaizumi Y, Tawara M, Joh T, Kohno T . Long-term study of indolent adult T-cell leukemia-lymphoma. Blood. 2010; 115(22):4337-43. DOI: 10.1182/blood-2009-09-242347. View

15.

Yamaguchi T, Ohshima K, Karube K, Tutiya T, Kawano R, Suefuji H . Clinicopathological features of cutaneous lesions of adult T-cell leukaemia/ lymphoma. Br J Dermatol. 2005; 152(1):76-81. DOI: 10.1111/j.1365-2133.2004.06274.x. View

16.

Itonaga H, Tsushima H, Taguchi J, Fukushima T, Taniguchi H, Sato S . Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience. Blood. 2012; 121(1):219-25. DOI: 10.1182/blood-2012-07-444372. View

17.

Fukushima T, Taguchi J, Moriuchi Y, Yoshida S, Itonaga H, Ando K . Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience. Int J Hematol. 2011; 94(4):390-394. DOI: 10.1007/s12185-011-0935-3. View

18.

Tsukasaki K, Krebs J, Nagai K, Tomonaga M, Koeffler H, Bartram C . Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood. 2001; 97(12):3875-81. DOI: 10.1182/blood.v97.12.3875. View

19.

Firouzi S, Lopez Y, Suzuki Y, Nakai K, Sugano S, Yamochi T . Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med. 2014; 6(6):46. PMC: 4097847. DOI: 10.1186/gm568. View

20.

Filipovich A, Weisdorf D, Pavletic S, Socie G, Wingard J, Lee S . National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005; 11(12):945-56. DOI: 10.1016/j.bbmt.2005.09.004. View